Envista Holdings Corp

Envista Holdings Corp is a U.S.-based dental products company built around more than 30 brands, including Nobel Biocare, Ormco, DEXIS, and Kerr. It sells implants, orthodontics, imaging, restorative, endodontic, rotary, and infection-prevention products used by dental professionals to diagnose, treat, and prevent oral disease.

12,2 %

54,7 %

1,7 %

+8,3 %

2.38

2.04

— Envista Holdings Corp
%
Specialty Products & Technologies64% Dental implant solutions and orthodontic products, including clear aligners and related treatment workflows.
Equipment & Consumables36% Diagnostic equipment, imaging, software, and consumable dental supplies used in daily practice.

Envista sells primarily to dental specialists and general practitioners, but its customer base also includes dental...

  • Dental specialistsprimary

    Orthodontists, implantologists, periodontists, and endodontists buy specialty systems and advanced clinical products for complex procedures.

  • General dentistsprimary

    General practitioners buy imaging, restorative, endodontic, and consumable products for routine diagnosis and treatment.

  • DSOsprimary

    Dental service organizations buy across multiple categories to standardize products, pricing, and workflows across practices.

  • Distributorsprimary

    Third-party distributors, especially Henry Schein, resell Envista products and are important for market access and scale.

  • Dental laboratories and institutionssecondary

    Labs, schools, medical entities, and governments buy specialized equipment and supplies for training, care delivery, and procurement.

Envista serves dental professionals in more than 130 countries, with sales concentrated in North America, Western...

  • •Sales span more than 130 countries through direct sales and distributors
  • •North America is the largest region and anchors the commercial network
  • •Western Europe is a major market for implants, imaging, and consumables
  • •Emerging markets are strategically important for growth and penetration
  • •Regional demand and FX swings affect reported sales and margins

Envista is focused on portfolio innovation, commercial expansion, and continued investment in its implant and...

01
Grow Spark clear aligner adoptionshort-term

Aligners are a key growth engine and benefit from deferred revenue timing and manufacturing scale.

02
Invest in portfolio development and product innovationmedium-term

New products and technologies support pricing power, customer retention, and category expansion.

03
Expand in emerging marketsmedium-term

These markets offer penetration upside and diversify growth beyond mature regions.

04
Use acquisitions to broaden the portfoliomedium-term

M&A can add technologies, brands, and geographic reach if integration is successful.

Envista is exposed to cyclical dental demand, distributor concentration, and intense competition across fragmented...

high

Distributor concentration

Henry Schein represented about 12% of 2025 sales and remains the largest channel partner.

Scope
Channel sales and U.S./Canada distribution
Materiality
high
high

Demand weakness in key markets

Dental procedures and equipment purchases can slow when economic conditions soften.

Scope
Global dental end markets, including China
Materiality
high
high

Goodwill and intangible impairment

Prior impairment charges show that valuation assumptions can change quickly if performance weakens.

Scope
Acquired brands, trade names, and technology assets
Materiality
high
medium

Trade policy and tariffs

Cross-border sourcing and manufacturing make the company sensitive to tariff changes and trade restrictions.

Scope
Global supply chain and international sales
Materiality
medium
medium

Foreign exchange volatility

A large share of revenue is outside the U.S., so currency moves affect reported sales and margins.

Scope
Europe and emerging markets
Materiality
medium
Deferred revenue in clear aligner treatment plans
Can materially affect quarterly growth and comparability
Goodwill and indefinite-lived intangible impairment
Can create significant non-cash charges to earnings
Acquired intangibles amortization
Affects operating profit and reported margins
Core sales non-GAAP measure
Useful for trend analysis but not a GAAP substitute

Enovis CORP

ENOV · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Envela Corp

ELA · Retail-Jewelry Stores

ENvue Medical, Inc.

FEED · Orthopedic, Prosthetic & Surgical Appliances & Supplies

ALIGN TECHNOLOGY INC

ALGN · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Envoy Medical, Inc.

COCH · Orthopedic, Prosthetic & Surgical Appliances & Supplies

DENTSPLY SIRONA Inc.

XRAY · Dental Equipment & Supplies

: 28/04/2026